These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2712917)

  • 41. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin.
    Akerlund M; Carlsson AM; Melin P; Trojnar J
    Acta Obstet Gynecol Scand; 1985; 64(6):499-504. PubMed ID: 4061066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo activity of the potent oxytocin antagonist on uterine activity in the rat.
    Ahn TG; Han SJ; Cho YS; An TH; Pak SC; Flouret G
    In Vivo; 2004; 18(6):763-6. PubMed ID: 15646817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antagonists for the human oxytocin receptor: an in vitro study.
    Maggi M; Fantoni G; Baldi E; Cioni A; Rossi S; Vannelli GB; Melin P; Akerlund M; Serio M
    J Reprod Fertil; 1994 Jul; 101(2):345-52. PubMed ID: 7932368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atosiban.
    Shubert PJ
    Clin Obstet Gynecol; 1995 Dec; 38(4):722-4. PubMed ID: 8616970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The inhibitory effect of ethanol on oxytocin-induced labor at term.
    Lauersen NH; Wilson KH; Fuchs FF
    J Reprod Med; 1981 Nov; 26(11):547-50. PubMed ID: 7338873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormality of calcium channel inhibitor released from fetal membranes in preterm labor.
    Carroll EM; Gianopoulos JG; Collins PL
    Am J Obstet Gynecol; 2001 Feb; 184(3):356-62. PubMed ID: 11228487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturanl myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygenation in the pregnant baboon during the last third of gestation.
    Nathanielsz PW; Honnebier MB; Mecenas C; Jenkins SL; Holland ML; Demarest K
    Biol Reprod; 1997 Aug; 57(2):320-4. PubMed ID: 9241045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Telemetric uterine contraction model in preterm cynomolgus monkeys.
    Chellman GJ; Bee WH; Resendez JC; Meyer JK; Bernal J; Moddrelle DS; Haluska GJ; Reinheimer TM
    Reprod Toxicol; 2004; 18(2):285-93. PubMed ID: 15019725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An oxytocin inhibitor for suppressing preterm labour.
    Turnbull AC
    Br J Obstet Gynaecol; 1987 Nov; 94(11):1009-11. PubMed ID: 3426978
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of oxytocin receptors and vasopressin V1a receptors in uterine contractions in rats: implications for tocolytic therapy with oxytocin antagonists.
    Chan WY; Wo NC; Manning M
    Am J Obstet Gynecol; 1996 Nov; 175(5):1331-5. PubMed ID: 8942510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor.
    Williams PD; Anderson PS; Ball RG; Bock MG; Carroll L; Chiu SH; Clineschmidt BV; Culberson JC; Erb JM; Evans BE
    J Med Chem; 1994 Mar; 37(5):565-71. PubMed ID: 8126695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress in the development of oxytocin antagonists for use in preterm labor.
    Pettibone DJ; Guidotti M; Harrell CM; Jasper JR; Lis EV; O'Brien JA; Reiss DR; Woyden CJ; Bock MG; Evans BE
    Adv Exp Med Biol; 1995; 395():601-12. PubMed ID: 8714024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban.
    Bossmar T
    J Perinat Med; 1998; 26(6):458-65. PubMed ID: 10224602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of uterine contractility with various tocolytics with and without progesterone: in vitro studies.
    Baumbach J; Shi SQ; Shi L; Balducci J; Coonrod DV; Garfield RE
    Am J Obstet Gynecol; 2012 Mar; 206(3):254.e1-5. PubMed ID: 22244470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using atosiban in uterine contractions of early pregnancies after assisted reproduction.
    Wu MY; Chen SU; Yang YS
    J Formos Med Assoc; 2011 Dec; 110(12):800. PubMed ID: 22248840
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of acupuncture on uterine contraction induced by oxytocin.
    Pak SC; Na CS; Kim JS; Chae WS; Kamiya S; Wakatsuki D; Morinaka Y; Wilson L
    Am J Chin Med; 2000; 28(1):35-40. PubMed ID: 10794115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of oxytocin and atosiban on the modulation of heart rate in pregnant women.
    Weissman A; Tobia RS; Burke YZ; Maxymovski O; Drugan A
    J Matern Fetal Neonatal Med; 2017 Feb; 30(3):329-333. PubMed ID: 27030149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxytocin inhibiting effect of the aqueous leaf extract of Ficus exasperata (Moraceae) on the isolated rat uterus.
    Bafor EE; Omogbai EK; Ozolua RI
    Acta Pol Pharm; 2011; 68(4):541-7. PubMed ID: 21796936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progress in the development of oxytocin antagonists for use in preterm labor.
    Williams PD; Bock MG; Evans BE; Freidinger RM; Pettibone DJ
    Adv Exp Med Biol; 1998; 449():473-9. PubMed ID: 10026841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxytocin receptor antagonists. Update.
    Goodwin TM; Zograbyan A
    Clin Perinatol; 1998 Dec; 25(4):859-71, vi. PubMed ID: 9891619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.